BRK-B vs NCPL
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
NCPL exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. The company is facing a liquidity crisis with a Current Ratio of 0.26 and a Quick Ratio of 0.18, suggesting an inability to meet short-term obligations. Catastrophic operating margins (-2362.17%) and a sharp decline in year-over-year revenue (-38.20%) point to a failing business model. With a 52-week price collapse from $8.75 to $0.42, the stock is in a technical death spiral with no visible catalyst for recovery.
Compare Another Pair
Related Comparisons
BRK-B vs NCPL: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Netcapital Inc. (NCPL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.